Abstract
Depression is the most frequent neuropsychiatric complication after a stroke. Post-stroke depression has a significant impact on the outcome and prognosis of affected patients. Its diagnosis is complex and currently based only on clinical parameters. In recent years, efforts have been made to find biomarkers related to post-stroke outcomes, including complications such as depression. We carried out a systematic review of the literature looking for studies that investigated biomarkers associated with post-stroke depression (PSD) in Medline, Lilacs and PsycInfo databases. The results of 37 studies are discussed, describing the evidence for each evaluated biomarker. In conclusion, no evidence was found supporting the use of a particular biomarker for PSD. However, several changes were observed in inflammatory balance, oxidative stress, glutamatergic neurotransmission, production of neurotrophic factors, and genetic susceptibility that can be related to PSD. Research in the area of post-stroke biomarkers has the potential to provide personalized approach of stroke patients, also aiding in the diagnosis and understanding of the pathophysiology of this common neuropsychiatric complication.
Keywords: Biomarkers, depression, review, stroke, neuropsychiatric.
Current Neurovascular Research
Title:Biomarkers in Post-stroke Depression
Volume: 13 Issue: 2
Author(s): Vinicius Sousa Pietra Pedroso, Milene Alvarenga Rachid and Antonio Lucio Teixeira
Affiliation:
Keywords: Biomarkers, depression, review, stroke, neuropsychiatric.
Abstract: Depression is the most frequent neuropsychiatric complication after a stroke. Post-stroke depression has a significant impact on the outcome and prognosis of affected patients. Its diagnosis is complex and currently based only on clinical parameters. In recent years, efforts have been made to find biomarkers related to post-stroke outcomes, including complications such as depression. We carried out a systematic review of the literature looking for studies that investigated biomarkers associated with post-stroke depression (PSD) in Medline, Lilacs and PsycInfo databases. The results of 37 studies are discussed, describing the evidence for each evaluated biomarker. In conclusion, no evidence was found supporting the use of a particular biomarker for PSD. However, several changes were observed in inflammatory balance, oxidative stress, glutamatergic neurotransmission, production of neurotrophic factors, and genetic susceptibility that can be related to PSD. Research in the area of post-stroke biomarkers has the potential to provide personalized approach of stroke patients, also aiding in the diagnosis and understanding of the pathophysiology of this common neuropsychiatric complication.
Export Options
About this article
Cite this article as:
Pietra Pedroso Sousa Vinicius, Rachid Alvarenga Milene and Teixeira Lucio Antonio, Biomarkers in Post-stroke Depression, Current Neurovascular Research 2016; 13 (2) . https://dx.doi.org/10.2174/1567202613666160219120114
DOI https://dx.doi.org/10.2174/1567202613666160219120114 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Training Pediatric Residents for Intervention on Tobacco
Current Pediatric Reviews Bone Marrow Cell Therapy in Clinical Trials: A Review of the Literature
Reviews on Recent Clinical Trials Correlation Between Circulating Adhesion Molecules and Resistin Levels in Hypertensive Type-2 Diabetic Patients
Inflammation & Allergy - Drug Targets (Discontinued) Cerebrovascular Diseases in HIV-Infected Patients
Current HIV Research Hematopoietic Growth Factors Support in the Elderly Cancer Patients Treated with Antiblastic Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Organoselenium Compounds as Potential Therapeutic and Chemopreventive Agents: A Review
Current Medicinal Chemistry Antihypertensive Therapy in Children: Differences in Medical Approach Between the United States and Europe
Current Medicinal Chemistry Stage B: What is the Evidence for Treatment of Asymptomatic Left Ventricular Dysfunction?
Current Cardiology Reviews Glucagon Like Peptide-1 and Atherosclerosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Incretin-Based Therapies in Patients with Type 2 Diabetes
Current Drug Therapy Amiodarone - A ‘Broad Spectrum’ Antiarrhythmic Drug
Cardiovascular & Hematological Disorders-Drug Targets Weight Loss in Obesity and Metabolic Syndrome
Current Hypertension Reviews The Role of Adipocytokines in Atherogenesis and Atheroprogression
Current Drug Targets New Agents – Manifold Consequences: The Management of Lung and Colorectal Cancer is Changing
Current Cancer Therapy Reviews Cardiovascular Imaging for Guiding Interventional Therapy in Structural Heart Diseases
Current Medical Imaging The Herpesvirus Encoded dUTPase as a Potential Chemotherapeutic Target
Current Protein & Peptide Science Meet Our Editorial Board Member
Current Medical Imaging Novel Inflammatory Biomarkers in Coronary Artery Disease: Potential Therapeutic Approaches
Current Medicinal Chemistry Postoperative Care of the Transplanted Patient
Current Cardiology Reviews Multiple Roles of Fibroblast Growth Factor 21 in Metabolism
Current Pharmaceutical Design